Author

C. R. R. Pao

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

P. T. Bozza· 4 shared A. C. Ferreira· 3 shared C. Q. Sacramento· 3 shared C. S. de Freitas· 3 shared D. C. Bou-Habib· 3 shared F. A. Bozza· 3 shared J. R. Temerozo· 3 shared M. Mattos· 3 shared

Activity by Year

2020-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

P. T. Bozza

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

ImmunologyPLOS PathogensPeer-reviewedAug 22, 2024

Host PGD2 acting on DP2 receptor attenuates Schistosoma mansoni infection-driven hepatic granulomatous fibrosis

G. N. Pezzella-Ferreira, C. R. R. Pao, I. Bellas…·C. Bandeira-Melo

This study investigates the role of PGD2 and its receptor DP2 in hepatic fibrosis caused by Schistosoma mansoni infection, finding that PGD2/DP2 signaling protects against fibrosis rather than promoting it.

DOI 10.1371/journal.ppat.1011812

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintAug 22, 2020

Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators

S. S. Gomes Dias, V. S. Cardoso, A. C. Ferreira…·P. T. Bozza

This study shows that lipid droplets support SARS-CoV-2 replication and inflammatory mediator production, with DGAT-1 inhibition reducing viral replication and inflammation.

DOI 10.1101/2020.08.22.262733

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivJul 25, 2020

VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells.

J. R. Temerozo, C. Q. Sacramento, N. Fintelman-Rodrigues…·D. C. Bou-Habib

The paper shows elevated VIP plasma levels in severe COVID-19 patients correlate with survival and protective effects against SARS-CoV-2 in vitro.

DOI 10.1002/jlb.5cova1121-626r

humanproteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintJun 15, 2020

The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2

C. Q. Sacramento, N. Fintelman-Rodrigues, J. R. Temerozo…·T. M. L. Souza

This study evaluates the antiviral activity of daclatasvir and sofosbuvir against SARS-CoV-2 in vitro, showing inhibition of viral replication and associated pathologies.

DOI 10.1101/2020.06.15.153411

humanexperimental assay

𝕏 PostBluesky